An official invitation letter will be provided upon successful registration for your participation in the conference.
Plenary, keynote and parallel sessions
Connect with global educators & researchers
Digital certificate of participation
Official invitation letter after successful registration
E-proceedings & resource materials
Learn from leading experts & scholars
The conference's session tracks effectively support the following SDGs.
This session will explore the underlying biological mechanisms that contribute to the development of diabetes and obesity. Emphasis will be placed on genetic, environmental, and metabolic factors influencing these conditions.
This track will focus on the latest advancements in diabetes management, including technology-driven solutions and novel pharmacological treatments. Discussions will highlight the impact of these innovations on patient outcomes.
This session will examine various intervention strategies for obesity, including lifestyle modifications, pharmacotherapy, and surgical options. The effectiveness and challenges of these approaches will be critically analyzed.
This track will delve into the psychological and social factors that influence diabetes and obesity management. Topics will include mental health, stigma, and the role of support systems.
This session will focus on dietary strategies and nutritional interventions aimed at preventing and managing diabetes and obesity. Evidence-based guidelines and innovative dietary patterns will be discussed.
This track will explore the role of physical activity in the prevention and management of diabetes and obesity. Research on exercise prescriptions and their physiological effects will be presented.
This session will address the disparities in diabetes and obesity prevalence and outcomes across different populations. Factors contributing to these disparities and potential solutions will be explored.
This track will investigate the emerging role of gut microbiota in the pathogenesis of diabetes and obesity. Discussions will focus on how microbiome modulation may offer new therapeutic avenues.
This session will review current pharmacological treatments for diabetes and obesity, including their mechanisms of action and clinical efficacy. Emerging drug candidates and their potential impact will also be discussed.
This track will highlight effective public health initiatives aimed at preventing diabetes and obesity at the population level. The role of policy, education, and community engagement will be emphasized.
This session will provide insights into the future research directions in the fields of diabetes and obesity. Emerging trends, technologies, and interdisciplinary approaches will be highlighted.